Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
6
×
boston
6
×
boston blog main
cancer
6
×
national blog main
boston top stories
life sciences
national top stories
new york blog main
clinical trials
foundation medicine
genentech
roche
san francisco blog main
startups
adeno-associated virus
australia
avapritinib
beam therapeutics
bill mckeon
biotech week boston
blueprint medicines
bristol-myers squibb
broad institute
bwb
cancer drugs
cancer immunotherapy
capmatinib
center for medicare and medicaid services
chemotherapy
cindy perettie
cisplatin
codiak biosciences
commercialization
companion diagnostic
crispr
cutaneous t-cell lymphoma
daniel o'day
david liu
deals
What
medicines
medicine
new
acquire
adding
address
ago
agreed
aiming
announced
approval
approves
balance
based
begin
benefiting
big
billion
biosciences
bio’s
blueprint
boston
brings
broad
bubbles
build
cancer
carries
cells
center
center’s
certain
class
clinical
codiak
coming
confidence
decibel
designed
diagnostics
Language
unset
Current search:
biotech
×
boston
×
cancer
×
@xconomy.com
3 years ago
Codiak Bio’s IPO Brings In $82M as Exosome Clinical Trials Begin
@xconomy.com
3 years ago
FDA Approves Blueprint Cancer Drug Targeting RET Genetic Signatures
@xconomy.com
4 years ago
Decibel Therapeutics Strikes a Balance, Adding Regenerative Med Focus
@xconomy.com
5 years ago
Laurie Glimcher To Headline Xconomy Keynote Series in Boston in September
@xconomy.com
5 years ago
JLabs’ Luby Takes the Reins at TMC Innovation Institute in Houston
@xconomy.com
5 years ago
In a Genentech Redux, Roche Pays $2.4B for Rest of Foundation Medicine